載入...
Biomarkers and Surrogate Endpoints: How and When might They Impact Drug Development?
As the pharmaceutical industry starts developing novel molecules developed based on molecular biology principles and a better understanding of the human genome, it becomes increasingly important to develop early indicators of activity and/or toxicity. Biomarkers are measurements based on molecular p...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
IOS Press
2002
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3850863/ https://ncbi.nlm.nih.gov/pubmed/12364814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2002/438745 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|